Scientific letters

• What have we learned from robotic-percutaneous coronary intervention so far? Early experience in a tertiary center

  María Tamargo, María Eugenia Vázquez, Enrique Gutiérrez, Manuela Rodríguez Ramos, Jaime Elízaga, Francisco Fernández-Avilés

  Rev Esp Cardiol. 2022;75:1075-7

• Mycotic pseudoaneurysm and aortitis caused by Candida sake

  Domingo Fernández Vecilla, Mikel Joseba Urrutikoetxea Gutiérrez, Estíbaliz Ugalde Zárraga, Maite Urizar Gorosarri, María Luisa Rodríguez Iriarte, José Luis Díaz de Tuesta del Arco

  Rev Esp Cardiol. 2022;75:1077-9

• Lung ultrasound in the follow-up of subclinical pulmonary congestion in outpatients with heart failure

  Mar Domingo, Germán Cediel, Pau Codina, Evelyn Santiago-Vacas, Antoni Bayés-Genís, Josep Lupón

  Rev Esp Cardiol. 2022;75:1079-80

• Sinus-SuperFlex-DS stent collapse in ductus arteriosus of a newborn with type B interrupted aortic arch

  Pedro Agudo-Montore, Inmaculada Guillén-Rodríguez, Begoña Manso-García, Antonio González-Calle, Félix Coserria-Sánchez

  Rev Esp Cardiol. 2022;75:959-60

• Healthcare-associated nosocomial and nosohusial infective endocarditis: are there any differences?

  Gloria Heredia Campos, Adriana Resúa Collazo, Consuelo Fernández-Avilés Irache, Paula Anguita Gámez, Juan C. Castillo Domínguez, Manuel Anguita Sánchez

  Rev Esp Cardiol. 2022;75:960-2

• Spontaneous echo-contrast and prothrombotic status in patients undergoing left atrial appendage occlusion

  Eduardo Flores-Umanzor, Pedro L. Cepas-Guillen, Laura Sanchis, Ander Regueiro, Maribel Díaz-Ricart, Xavier Freixa

  Rev Esp Cardiol. 2022;75:963-5

• Predictive value of atropine response in patients with bradyarrhythmia in the presence of bradycardic drugs

  Luis Álvarez-Acosta, Leydimar Anmad Shihadeh, Lina I. Pérez-Méndez, Nerea Torres González, Pablo Ruiz-Hernández, Julio Hernández-Afonso

  Rev Esp Cardiol. 2022;75:966-7

• Description of a novel variant in the FHL1 gene associated with hypertrophic cardiomyopathy with early and aggressive presentation

  María López Blázquez, Ana Isabel Fernández Ávila, Reyes Álvarez García-Rovés, Miriam Centeno Jiménez, Cristina Gómez González, María Ángeles Espinosa Castro

  Rev Esp Cardiol. 2022;75:968-70

• Lipoprotein(a) in a selection of hospitals in Andalusia and Extremadura. Underdiagnosed and underused?

  Teresa Arrobas Velilla, Juan Fabiani de la Iglesia, Salomon Martín Pérez, Luis Calbo Caballos, Jose Javier Gómez Barrado, Antonio León Justel, en representación del Grupo de Trabajo de Riesgo Cardiovascular de la Sociedad Andaluza de Análisis Clínicos y colaboradores

  Rev Esp Cardiol. 2022;75:844-5

• Fabry cardiomyopathy: parametric mapping adds even more

  Virginia Ruiz Pizarro, Jorge Álvarez Rubio, María Jesús Soleto Roncero, Tomás Ripoll-Vera

  Rev Esp Cardiol. 2022;75:845-7

• Which patients could benefit from the use of bempedoic acid in clinical practice?

  Vivencio Barrios, Carlos Escobar

  Rev Esp Cardiol. 2022;75:847-8

• Survival after out-of-hospital cardiopulmonary resuscitation before ambulance arrival in the Basque Country

  Sendoa Ballesteros-Peña, Mario Ernesto Jiménez-Mercado, Irrintzi Fernández-Aedo

  Rev Esp Cardiol. 2022;75:848-50

• A new mutation in the ACTA1 gene possibly associated with dilated cardiomyopathy without concomitant myopathy

  Arancha Díaz Expósito, Ainhoa Robles Mezcua, Alejandro I. Pérez Cabeza, José Manuel García Pinilla

  Rev Esp Cardiol. 2022;75:850-2

• Genetic testing in suspected inherited aortopathies: usefulness in diagnosis and follow-up

  Víctor M. Becerra-Muñoz, Arancha Díaz-Expósito, Victoria Doncel-Abad, Patricia Fernández-García, José Luis López-Benítez, Fernando Cabrera-Bueno

  Rev Esp Cardiol. 2022;75:765-7

• Use of POCUS in cardiovascular screening of young athletes: diagnostic value in the era of international electrocardiographic criteria

  Óscar Fabregat-Andrés, Francisco-José Ferrer-Sargues, Elena Lucas-Inarejos, Pablo Vera-Ivars, Alfonso A. Valverde-Navarro, Carlos Barrios-Pitarque

  Rev Esp Cardiol. 2022;75:767-9

• Microvascular dysfunction and invasive absolute coronary flow after percutaneous coronary intervention for a chronic total occlusion. The FLOW-CTO study

  Marcos García-Guimarães, Alejandro Gutiérrez-Barrios, Josep Gómez-Lara, Álvaro Aparisi, Neus Salvatella, Fernando Rivero

  Rev Esp Cardiol. 2022;75:769-71

• Introduction of the Ozaki technique in Spain. A new procedure for congenital aortic valve plasty?

  Álvaro González Rocafort, Bunty Kishore Ramchandani Ramchandani, Juvenal Rey Lois, Luz Polo López, Raúl Sánchez Pérez, Tomasa Centella Hernández

  Rev Esp Cardiol. 2022;75:771-3

• Second victims and quality of support resources among cardiology professionals

  Jordi Bañeras, Pablo Jorge-Pérez, Clara Bonanad, María Thiscal López Lluva, Isaac Moll, Sara Guila Fidel Kinori

  Rev Esp Cardiol. 2022;75:686-8

• Percutaneous left atrial appendage closure without subsequent antiplatelet treatment in patients with a history of very severe bleeding

  Leire Unzué, Eulogio García, Belén Díaz-Antón, Rodrigo Teijeiro-Mestre, Miguel Rodríguez del Río, Francisco Javier Parra

  Rev Esp Cardiol. 2022;75:688-90

• Tropical endomyocardial fibrosis, a neglected disease. Case series in Cameroon

  Sofía Cuenca, Marie Philomène Bitchou, Gonzalo Morales-Jiménez

  Rev Esp Cardiol. 2022;75:690-2